{
  "index": "56dM7tLih1U",
  "title": "3 Development of Rift Valley fever vaccine suitable for human and livestock use - George Warimwe",
  "url": "https://www.youtube.com/watch?v=56dM7tLih1U",
  "category": "Science & Technology",
  "video_id": "56dM7tLih1U",
  "tasks": [
    {
      "task": "Presenting a vaccine development case study for Rift Valley fever.",
      "task_start": 857.92,
      "task_end": 861.12,
      "task_match_score": 100.0,
      "task_time_method": "task_text_match",
      "subtasks": [
        {
          "text": "Introduction and background on the speaker's work.",
          "segment_id": 483,
          "match_score": 100.0,
          "start": 1155.2,
          "end": 1159.28
        },
        {
          "text": "Explanation of the need to consider One Health in vaccine development.",
          "segment_id": 352,
          "match_score": 100.0,
          "start": 857.92,
          "end": 861.12
        },
        {
          "text": "Description of Rift Valley fever, its transmission, and impact on livestock and humans.",
          "segment_id": 483,
          "match_score": 100.0,
          "start": 1155.2,
          "end": 1159.28
        },
        {
          "text": "Discussion of current vaccine options for livestock and the need for a human vaccine.",
          "segment_id": 352,
          "match_score": 100.0,
          "start": 857.92,
          "end": 861.12
        },
        {
          "text": "Description of the Chadoks vaccine platform and its use in developing the RVF vaccine.",
          "segment_id": 352,
          "match_score": 100.0,
          "start": 857.92,
          "end": 861.12
        },
        {
          "text": "Presentation of preclinical and livestock trial results, emphasizing safety and efficacy.",
          "segment_id": 425,
          "match_score": 100.0,
          "start": 1024.319,
          "end": 1028.4
        },
        {
          "text": "Explanation of field trial plans and ongoing analysis for regulatory approval.",
          "segment_id": 425,
          "match_score": 100.0,
          "start": 1024.319,
          "end": 1028.4
        },
        {
          "text": "Overview of the human phase one trial and expected outcomes.",
          "segment_id": 425,
          "match_score": 100.0,
          "start": 1024.319,
          "end": 1028.4
        },
        {
          "text": "Addressing the challenges in predicting outbreaks for vaccine efficacy studies.",
          "segment_id": 185,
          "match_score": 100.0,
          "start": 449.12,
          "end": 452.8
        },
        {
          "text": "Discussion of regulatory strategies and stakeholder engagement for vaccine deployment.",
          "segment_id": 352,
          "match_score": 100.0,
          "start": 857.92,
          "end": 861.12
        },
        {
          "text": "Q&A session highlighting interdisciplinary collaboration and personal experiences.",
          "segment_id": null,
          "match_score": 50.0,
          "start": null,
          "end": null
        }
      ]
    }
  ]
}